Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease
Introduction There is an urgent need to determine the safety, effectiveness and cost-effectiveness of novel antiviral treatments for COVID-19 in vaccinated patients in the community at increased risk of morbidity and mortality from COVID-19.Methods and analysis PANORAMIC is a UK-wide, open-label, pr...
Saved in:
| Main Authors: | Najib Rahman, Andrew Carson-Stevens, Stavros Petrou, Judith Breuer, Paul Little, Melissa Dobson, Kerenza Hood, Jienchi Dorward, May Ee Png, Richard Hobbs, Gail Hayward, Mark Lown, Nigel Hart, Ly-Mee Yu, Nick Francis, Oliver van Hecke, Julie Allen, Joseph F Standing, Emma Ogburn, Jennifer Davies, Christopher C Butler, Saye Khoo, Andrew Ustianowski, Victoria Harris, Bhautesh Jani, Jane Holmes, Heather Rutter, Oghenekome Gbinigie, Lucy Cureton, Sarah Barrett, Benjamin R Saville, Monique I Andersson, Mahendra Patel, Jonathan Nguyen-Van-Tam, Duncan Richards, Layla Lavallee, David M Lowe, Tracie-Ann Madden, Joe Marion, Jem Chalk, Elizabeth Hadley, Magdalena Benysek, Mona Koshkouei, Maria Coates, Clare Bateman, Ivy Raymundo-Wood |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-08-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/13/8/e069176.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE): protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk
by: Sarah Tonkin-Crine, et al.
Published: (2021-06-01) -
Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV)Research in context
by: Podjanee Jittamala, et al.
Published: (2025-02-01) -
Adaptive modification of antiviral defense systems in microbial community under Cr-induced stress
by: Dan Huang, et al.
Published: (2025-01-01) -
Rapid-response RNA-fluorescence in situ hybridization (FISH) assay platform for coronavirus antiviral high-throughput screening
by: Ryan Chan, et al.
Published: (2024-12-01) -
AVP-GPT2: A Transformer-Powered Platform for De Novo Generation, Screening, and Explanation of Antiviral Peptides
by: Huajian Zhao, et al.
Published: (2024-12-01)